Résultats: 9

    Guideline No. 426: Hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management

    J. obstet. gynaecol. Can; 44 (5), 2022
    This guideline was developed by maternity care providers from obstetrics and internal medicine. It reviews the diagnosis, evaluation, and management of the hypertensive disorders of pregnancy (HDPs), the prediction and prevention of preeclampsia, and the postpartum care of women with a previous HDP. Impl...

    WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia

    In 2019, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia. This decision was based on new evidence on the ...

    WHO recommendation on Calcium supplementation before pregnancy for the prevention of pre-eclampsia and its complications

    The primary goal of this recommendation is to improve the quality of care and outcomes for pregnant women and women intending to become pregnant, particularly those related to prevention of pre-eclampsia, eclampsia and resulting complications. This recommendation may be of interest to professional societ...

    Hypertension in pregnancy: diagnosis and management

    This guideline covers diagnosing and managing hypertension (high blood pressure), including preeclampsia, during pregnancy, labour and birth. It also includes advice for women with hypertension who wish to conceive and women who have had a pregnancy complicated by hypertension. It aims to improve care du...

    WHO recommendation: calcium supplementation during pregnancy for prevention of pre-eclampsia and its complications

    Improving care for women during pregnancy and around the time of childbirth to prevent and treat pre-eclampsia and eclampsia is a necessary step towards the achievement of the health targets of the Sustainable Development Goals (SDGs). Efforts to prevent and reduce morbidity and mortality due to these co...

    WHO recommendations: policy of interventionist versus expectant management of severe pre-eclampsia before term

    The Department of Reproductive Health and Research of the World Health Organization gratefully acknowledges the contributions of many individuals and organizations to the updating of these recommendations. Work on this update was coordinated by Olufemi Oladapo, Joshua Vogel and A. Metin Gülmezoglu of th...

    Calcium supplementation in pregnant women

    Poor maternal and newborn health and nutrition remain significant contributors to the burden of disease and mortality. Calcium supplementation has the potential to reduce adverse gestational outcomes, in particular by decreasing the risk of developing hypertensive disorders during pregnancy, which are as...

    WHO recommendations for Prevention and treatment of pre-eclampsia and eclampsia

    Hypertensive disorders of pregnancy are an important cause of severe morbidity, longterm disability and death among both mothers and their babies. In Africa and Asia, nearly one tenth of all maternal deaths are associated with hypertensive disorders of pregnancy, whereas one quarter of maternal deaths in...